Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
about
Alzheimer mechanisms and therapeutic strategiesPresenilin-1 regulates the expression of p62 to govern p62-dependent tau degradationEvidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusibAmyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta poresGrowing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and BehaviorInflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's DiseaseUBA1: At the Crossroads of Ubiquitin Homeostasis and NeurodegenerationThe Possible Roles of the Dentate Granule Cell's Leptin and Other Ciliary Receptors in Alzheimer's Neuropathology'The clocks that time us'--circadian rhythms in neurodegenerative disordersProtective effects and mechanisms of sirtuins in the nervous systemCombotherapy and current concepts as well as future strategies for the treatment of Alzheimer's diseaseThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsPathogenic protein seeding in Alzheimer disease and other neurodegenerative disordersThe pericyte: a forgotten cell type with important implications for Alzheimer's disease?Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysisNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsConnecting the dots between tau dysfunction and neurodegenerationInconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's diseaseHormesis in aging and neurodegeneration-a prodigy awaiting dissectionHijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearanceTau-targeted treatment strategies in Alzheimer's diseaseAcetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment.The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model miceElucidation of monocyte/macrophage dynamics and function by intravital imaging.Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in MiceInduced tauopathy in a novel 3D-culture model mediates neurodegenerative processes: a real-time study on biochipsMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesThe role of leptin in central nervous system diseasesDefective control of pre-messenger RNA splicing in human diseaseCompartmentalized Platforms for Neuro-Pharmacological ResearchAbnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damageThe Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and TherapyTau promotes neurodegeneration via DRP1 mislocalization in vivoEnvironmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticityCoffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cellsFisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factorsInhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiolAntiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive CompoundsCentral angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brainsMicrotubule-associated protein tau is essential for long-term depression in the hippocampus
P2860
Q22252311-0E2A9319-3A2F-46B5-B32F-042323180EE5Q24296704-C1F7980C-3C72-4F44-927E-2D5EF5B44429Q24610904-975F7F79-B1A5-4A15-9C04-208B6C408615Q26738355-FCBCD6C2-7056-4286-9164-DFE3AF43D219Q26766519-906E900D-13DA-4599-9FEC-78D74A3974A7Q26773657-7782EF84-4B72-4EE0-9808-6C161BA8FDABQ26782551-8066A8B1-E4D5-4125-A062-54E6FDDF5149Q26799897-23BA9DF2-7F8D-41FE-8371-2836FEAFFE21Q26824646-4EF61B08-30FB-4031-8EDC-D16DBE6EF4F5Q26825585-A1F06E6C-1693-408C-88F4-06519624EE03Q26829899-3E49F640-D613-4B8F-BB8D-AA1C7AEEA0B7Q26830467-0A9925A3-1277-49DE-8BF8-567F4A079CF0Q26850298-6436F381-962D-430A-BC65-4F4F1B93B7B3Q26852369-2BC8F215-5F51-4F2D-8E38-B42AB08747E9Q26861399-077277A5-FF76-4DEE-AD0F-C26F2C76097DQ26866006-9CABB32A-C6B8-46CE-B867-A81C986C2BE6Q26996848-F281F747-212C-4998-BC00-EEB9C06AE72EQ27003841-55625391-3423-438A-8211-301D04F67AAAQ27003901-D02211A2-79DB-445D-AD72-FF3660F25A00Q27009790-725EE255-86F2-4A19-865E-E5B88F6DBA44Q27023429-78901DE9-53C8-4705-AE33-09292094FDCBQ27301070-74227446-C4A1-4C7D-8616-8E54FD9BC941Q27305145-E5E97561-DFF9-491D-B3F5-CF7FA95E7390Q27313900-062F123D-ECE0-424B-A622-2B51A1B3D04FQ27334314-FFE263E0-79F6-4EBD-85FE-5859A7A33594Q27338805-B2A77E69-ABD2-42C3-9262-7D057724CA75Q28066691-0F03F101-2603-40DD-99C7-00703F570576Q28069664-03D231F5-27D8-4028-B8A2-812922A593B1Q28077564-84E600E6-D19C-485A-97FA-D4C3AD3EF49AQ28078426-401D335E-5991-40FD-802E-A1E42DD87F45Q28114981-8215F251-C42B-4530-B0B7-FA58074CB0D8Q28119005-765DFBA1-9D7A-4DEA-8A5B-21C6131C2455Q28119104-C2DBD18D-C19E-451D-9D90-36055373293FQ28304384-19F3E742-993C-49AF-90C9-C91A338F0656Q28385402-CED100DE-3CBE-40DD-BF08-B0250599FE5BQ28393031-031A77D0-7AB8-4AED-919E-AC64F239FD7CQ28478362-B8CCED50-191F-4DA2-9167-5CEAC920EB33Q28550688-F98AA404-D3FB-427A-92A9-97349F24D35FQ28577666-87FBDFFD-CE01-4CA1-A11D-35BE91F2EB74Q28584008-3D28CFC3-8384-4D06-B0C9-A30DAF1A5519
P2860
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@en
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@nl
type
label
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@en
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@nl
prefLabel
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@en
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@nl
P356
P1476
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
@en
P2888
P356
10.1038/NRN2967
P407
P577
2010-12-31T00:00:00Z